Literature DB >> 16075327

Effect of topical unoprostone isopropyl on optic nerve head circulation in controls and in normal-tension glaucoma patients.

Itaru Kimura1, Kei Shinoda, Tomihiko Tanino, Yuichiro Ohtake, Yukihiko Mashima.   

Abstract

PURPOSE: To evaluate the effect of unoprostone isopropyl on microcirculation in the optic nerve head (ONH) of controls and patients with normal-tension glaucoma (NTG).
METHODS: Thirty healthy volunteers were randomly placed in a placebo group or a control group. For ten NTG patients, one eye was selected to receive the placebo drops and the contralateral eye received the unoprostone in a masked fashion. In both studies, the intraocular pressure (IOP) and the parameters of the blood hemodynamics of the ONH were obtained before and at 1 and 2 h after the instillation. Blood flow measurements were made with a scanning laser Doppler flowmeter.
RESULTS: In both control subjects and NTG patients, the changes in the IOPs after the instillation of either unoprostone or the placebo were not significant because almost all of the NTG patients had IOPs lower than 15 mmHg. Although the hemodynamic parameters were not significantly changed in the placebo-treated eyes of the controls, the eyes of the controls treated with unoprostone had mean blood velocity and flow values that were significantly higher than the baseline values 1 and 2 h after instillation (P < 0.01). The velocity values of the controls treated with unoprostone were significantly higher than in those controls receiving the placebo at 2 h postinstillation (P = 0.027). The values for the three circulation parameters (volume, velocity, flow) were significantly higher than the baseline values after instillation in the eyes of the NTG patients treated with unoprostone (P < 0.05). In contrast, none of these parameters was significantly different from the baseline in the eyes of NTG patients treated with placebo.
CONCLUSIONS: These results showed that unoprostone significantly increased microcirculation in the ONH in control subjects and in NTG patients without reducing the IOP significantly. (c) Japanese Ophthalmological Society 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16075327     DOI: 10.1007/s10384-004-0208-2

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  32 in total

1.  Comparison of the cardiovascular effects of unoprostone 0.15%, timolol 0.5% and placebo in healthy adults during exercise using a treadmill test.

Authors:  William C Stewart; Jeanette A Stewart; Steve Crockett; Christine Kubilus; Alison Brown; Naveed Shams
Journal:  Acta Ophthalmol Scand       Date:  2002-06

2.  Principle, validity, and reliability of scanning laser Doppler flowmetry.

Authors:  G Michelson; B Schmauss; M J Langhans; J Harazny; M J Groh
Journal:  J Glaucoma       Date:  1996-04       Impact factor: 2.503

3.  Influence of pindolol and timolol treatment on the visual fields of glaucoma patients.

Authors:  J Flammer; Y Robert; B Gloor
Journal:  J Ocul Pharmacol       Date:  1986

4.  [Clinical evaluation of UF-021 ophthalmic solution in glaucoma patients refractory to maximum tolerable therapy].

Authors:  I Azuma
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1993-02

Review 5.  The vascular concept of glaucoma.

Authors:  J Flammer
Journal:  Surv Ophthalmol       Date:  1994-05       Impact factor: 6.048

6.  [The intraocular pressure lowering effects of UF-021, a novel prostaglandin related compound, in animals].

Authors:  R Ueno; S Yoshida; T Deguchi; I Kato; T Oda; Y Hayashi; S Kuno
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1992-04

7.  Progression of field loss after trabeculectomy: a five-year follow-up.

Authors:  M N Kidd; M O'Connor
Journal:  Br J Ophthalmol       Date:  1985-11       Impact factor: 4.638

8.  Effect of UF-021 on optic nerve head circulation in rabbits.

Authors:  T Sugiyama; I Azuma
Journal:  Jpn J Ophthalmol       Date:  1995       Impact factor: 2.447

9.  Association of endothelin-1 with normal tension glaucoma: clinical and fundamental studies.

Authors:  T Sugiyama; S Moriya; H Oku; I Azuma
Journal:  Surv Ophthalmol       Date:  1995-05       Impact factor: 6.048

10.  Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.

Authors:  Douglas G Day; Paul N Schacknow; Martin Wand; Elizabeth D Sharpe; Jeanette A Stewart; Jessica Leech; William C Stewart
Journal:  Am J Ophthalmol       Date:  2003-02       Impact factor: 5.258

View more
  10 in total

1.  Regeneration of optic nerve fibers with unoprostone, a prostaglandin-related antiglaucoma drug, in adult cats.

Authors:  Hiroe Sagawa; Hiroko Terasaki; Keiko Nakanishi; Yoshihito Tokita; Masami Watanabe
Journal:  Jpn J Ophthalmol       Date:  2013-10-16       Impact factor: 2.447

Review 2.  Effects of antiglaucoma drugs on blood flow of optic nerve heads and related structures.

Authors:  Chihiro Mayama; Makoto Araie
Journal:  Jpn J Ophthalmol       Date:  2013-01-16       Impact factor: 2.447

Review 3.  Pharmacotherapy of glaucoma.

Authors:  Doreen Schmidl; Leopold Schmetterer; Gerhard Garhöfer; Alina Popa-Cherecheanu
Journal:  J Ocul Pharmacol Ther       Date:  2015-01-14       Impact factor: 2.671

4.  Decreased blood flow at neuroretinal rim of optic nerve head corresponds with visual field deficit in eyes with normal tension glaucoma.

Authors:  Enrique Adan Sato; Yuichiro Ohtake; Kei Shinoda; Yukihiko Mashima; Itaru Kimura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-11-29       Impact factor: 3.117

5.  Topical isopropyl unoprostone for retinitis pigmentosa: microperimetric results of the phase 2 clinical study.

Authors:  Shuichi Yamamoto; Takeshi Sugawara; Akira Murakami; Mitsuru Nakazawa; Nobuhisa Nao-I; Shigeki Machida; Yuko Wada; Yukihiko Mashima; Yozo Myake
Journal:  Ophthalmol Ther       Date:  2012-09-06

6.  Effect of topical isopropyl unoprostone on macular atrophy progression in eyes with exudative age-related macular degeneration.

Authors:  Chieko Shiragami; Masahiro Miyake; Atsushi Fujiwara; Yuki Morizane; Akitaka Tsujikawa; Ayana Yamashita; Fumio Shiraga
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

7.  Recent advances in pharmacotherapy of glaucoma.

Authors:  S K Gupta; Galpalli Niranjan D; S S Agrawal; Sushma Srivastava; Rohit Saxena
Journal:  Indian J Pharmacol       Date:  2008-10       Impact factor: 1.200

8.  Improvement of central retinal sensitivity six months after topical isopropyl unoprostone in patients with retinitis pigmentosa.

Authors:  Ayako Tawada; Takeshi Sugawara; Kazuha Ogata; Akira Hagiwara; Shuichi Yamamoto
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

Review 9.  An evidence-based review of unoprostone isopropyl ophthalmic solution 0.15% for glaucoma: place in therapy.

Authors:  Derrick S Fung; Jess T Whitson
Journal:  Clin Ophthalmol       Date:  2014-03-10

10.  Intraocular pressure and visual field changes in normal-tension glaucoma patients treated using either unoprostone or latanoprost: a prospective comparative study.

Authors:  Daisuke Takemoto; Tomomi Higashide; Yoshiaki Saito; Shinji Ohkubo; Sachiko Udagawa; Hisashi Takeda; Kazuhisa Sugiyama
Journal:  Clin Ophthalmol       Date:  2017-09-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.